Literature DB >> 11452721

Can [15O]water be used to evaluate drugs?

P Herscovitch1.   

Abstract

There is an extensive literature supporting the use of rCBF as a surrogate marker of local neuronal activity. This provides a strong physiologic rationale for using PET measurements of rCBF to study the effects of drugs acting on the brain. The ability to perform multiple brief measurements of rCBF with [15O]water in a single study session makes possible a wide variety of experimental designs. Numerous investigators have successfully applied the method to study a wide variety of centrally acting drugs. In summary, then, the answer to the question, "Can [15O]water be used to evaluate drugs?" is a definitive yes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11452721

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN: 0091-2700            Impact factor:   3.126


  8 in total

1.  A possible substrate for dopamine-related changes in mood and behavior: prefrontal and limbic effects of a D3-preferring dopamine agonist.

Authors:  Kevin J Black; Tamara Hershey; Jonathan M Koller; Tom O Videen; Mark A Mintun; Joseph L Price; Joel S Perlmutter
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-13       Impact factor: 11.205

2.  Quantification of indirect pathway inhibition by the adenosine A2a antagonist SYN115 in Parkinson disease.

Authors:  Kevin J Black; Jonathan M Koller; Meghan C Campbell; Debra A Gusnard; Stephen I Bandak
Journal:  J Neurosci       Date:  2010-12-01       Impact factor: 6.167

3.  Methylphenidate-induced activation of the anterior cingulate but not the striatum: a [15O]H2O PET study in healthy volunteers.

Authors:  Joanna I Udo de Haes; R Paul Maguire; Piet L Jager; Anne M J Paans; Johan A den Boer
Journal:  Hum Brain Mapp       Date:  2007-07       Impact factor: 5.038

4.  Flow-metabolism dissociation in the pathogenesis of levodopa-induced dyskinesia.

Authors:  Vincent A Jourdain; Chris C Tang; Florian Holtbernd; Christian Dresel; Yoon Young Choi; Yilong Ma; Vijay Dhawan; David Eidelberg
Journal:  JCI Insight       Date:  2016-09-22

5.  Dissociation of metabolic and neurovascular responses to levodopa in the treatment of Parkinson's disease.

Authors:  Shigeki Hirano; Kotaro Asanuma; Yilong Ma; Chengke Tang; Andrew Feigin; Vijay Dhawan; Maren Carbon; David Eidelberg
Journal:  J Neurosci       Date:  2008-04-16       Impact factor: 6.167

6.  Prolactin and fMRI response to SKF38393 in the baboon.

Authors:  Brad Miller; Lauren A Marks; Jonathan M Koller; Blake J Newman; G Larry Bretthorst; Kevin J Black
Journal:  PeerJ       Date:  2013-10-29       Impact factor: 2.984

7.  Arterial spin labeling versus BOLD in direct challenge and drug-task interaction pharmacological fMRI.

Authors:  Stephanie B Stewart; Jonathan M Koller; Meghan C Campbell; Kevin J Black
Journal:  PeerJ       Date:  2014-12-11       Impact factor: 2.984

8.  Rapid quantitative pharmacodynamic imaging by a novel method: theory, simulation testing and proof of principle.

Authors:  Kevin J Black; Jonathan M Koller; Brad D Miller
Journal:  PeerJ       Date:  2013-08-01       Impact factor: 2.984

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.